Concepedia

Publication | Open Access

Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials

DOIFull Paper Access

293

Citations

6

References

2016

Year

Rik Vandenberghe, Juha O. Rinne, Merçé Boada, Sadao Katayama, Philip Scheltens, Bruno Vellas, Michael Tuchman, Achim Gass, Jochen B. Fiebach, Kasia Lobello,
Alzheimer s Research & Therapy

References

YearCitations

Page 1